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1. Introduction 
The steroidogenic response of the interstitial cells 
of the testis to luteinizing hormone (LH) and human 
chorionic gonadotropin (hCG) has been clearly 
demonstrated bynumerous studies in vivo and in 
vitro. Both LH and hCG have been shown to increase 
cyclic AMP formation and testosterone production 
in isolated testis tissue [1-4] and in dispersed 
interstitial cells [4-6].  Also, exogenous cyclic AMP 
and dibutyryl cyclic AMP stimulate testosterone 
synthesis by interstitial tissue [2,7], and the sensitivity 
of the androgen response to gonadotropin s enhanced 
by phosphodiesterase inhibitors [6]. These observa- 
tions are consistent with a role of cyclic AMP as an 
intracellular mediator of gonadotropic a tivation of 
steroidogenesis. However, recent studies have shown 
that the testosterone r sponse of isolated testes [8] 
and interstitial cells [6] to low gonadotropin concen- 
trations is not accompanied by a detectable change 
in cyclic AMP levels. 
While there could be several explanations for the 
absence of a cyclic AMP response during gonado- 
tropic stimulation of testosterone production [6], 
an important possibility is that the second messenger 
function could also be performed by cyclic GMP. 
Such an action of cyclic GMP has been proposed to 
occur in the steroidogenic response of isolated adrenal 
cells to ACTH [9] where cyclic AMP levels and corti- 
costerone production show a discrepancy [10,11 ]
which is less marked than that observed in the 
testicular interstitial cell [6]. The present studies 
were performed to explore the possibility that a 
change in cyclic GMP concentration could be 
correlated with the action of low concentrations of 
gonadotropin upon steroidogenesis in isolated 
interstitial cells of the rat testis. 
2. Materials 
Guanosine 3':5'-cyclic monophosphate (cyclic 
GMP) and N 2 ,O 2'-dibutyryl guanosine-3': 5 -cyclic 
monophosphate (dibutyryl cyclic GMP) were pur- 
chased from Sigma, adenosine 3':5'-cyclic mono- 
phosphate (cyclic AMP) from Calbiochem, and 
testosterone from Steroloids; 12SI-succinyl cyclic 
GMP-tyrosine methyl ester (12sI-SCGMP-TME) and 
antibody to SCGMP-TME were obtained from 
Schwarz/Mann. 12SI-Succinyl cyclic AMP-tyrosine 
methyl ester (12sI-SCAMP-TME) was from Collabo- 
rative Research, and [1,2-3H] testosterone (40 Ci/ 
mmol) from New England Nuclear. Antibody to 
succinyl cyclic AMP coupled to bovine serum albumin, 
and antibody to testosterone coupled to bovine 
gamma globulin, were prepared as previously described 
• [3,12]. 1-Methyl 3-isobutylxanthine (MIX) was 
obtained from G. D. Seafle and bovine serum albumin 
(BSA) from Metrix. Medium 199 and collagenase 
(Type I; 238 U/mg) were purchased from Microbio- 
logical Associates and Worthington, respectively. The 
purified hCG used in these studies was generously 
provided by Dr R. E. Canfield, Department of 
Medicine, Columbia University. 
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3. Methods 
3.1. Preparation and incubation of interstitial cells 
Interstitial cell preparations were obtained by 
collagenase digestion of decapsulated testes from 
adult Sprague-Dawley rats as previously described 
[4,6]. Dispersed interstitial cells were incubated at 
34°C in polyethylene counting vials (Packard) under 
95% O2-5% CO2 with shaking at 100 cycles/min. 
Cells and all additions were prepared in Medium 199 
supplemented with 0.1% BSA. Each incubation vial 
contained 2 ml of cell suspension, 0.1 ml of 2 mM 
MIX and 0.1 rnl of standard solutions of hCG or 
dibutyryl cyclic GMP. 
3.2. Production of testosterone and cyclic nucleotides 
Testosterone was determined in the incubation 
medium by radioimmunoassay after removal of cells 
by centrifugation at 1400 × g for 15 min [ 12]. Cyclic 
GMP and cyclic AMP were measured by radioimmuno- 
assay in aliquots of the cell suspension after immersion 
in a boiling water bath for 10 min and centrifugation 
at 1400 × g for 10 min. Cyclic AMP was determined by 
a modification [3] of the method of Steiner et al. 
[13], and cyclic GMP was measured after acetylation 
by the method of Harper and Brooker [14]. The 
sensitivity of the cyclic GMP assay was found to be 
the same as that of the succinylation method of 
Cailla et al. [15], between 2 and 5 fmol, and closely 
similar cyclic GMP values for tissue extracts were 
obtained by both methods. Samples to be assayed 
for cyclic nucleotides were incubated overnight at 
4°C with 12SI-SCGMP-TME or 12SI-SCAMP-TME and 
antibody to cyclic GMP or cyclic AMP, and the 
bound fraction was then separated by dioxane 
precipitation [3]. The radioimmunoassay for cyclic 
GMP gave parallel slopes for tissue extracts and 
samples of incubation medium, and was shown to 
detect a rise in cyclic GMP content of uterine tissue 
of estradiol-treated rats which was comparable with 
that described by Kuehl et al. [16]. 
4. Results 
4.1. Effects of dibutyryl cyclic GMP on testosterone 
production 
Interstitial cells were incubated for 3 h with 10 -s, 
Table 1 
Effects of dibutyryl cyclic GMP and hCG on testosterone 
production by isolated interstitial cell preparations 
during incubation for 3 h 
Testosterone production 
Additions (pmol/107 cells) 
None 20.1 ± 1.4 a 
Dibutyryl Cyclic GMP 
10 -s M 22.5 ± 1.1 
10 -4 M 19.9 +- 1.4 
10 -a M 20.1 +- 1.5 
hCG (10 ng/vial) 135.9 ± 13.3 
a Mean of triplicate incubations, + SEM 
10 -4, or 10 -a M dibutyryl cyclic GMP, and testosterone 
production was determined by radioimmunoassay. 
None of the concentrations of dibutyryl cyclic GMP 
caused a significant change in testosterone production 
(table I). However, cells incubated with hCG (10 ng/ 
vial) showed markedly increased testosterone produc- 
tion, demonstrating that the cell preparation was 
capable of increased steroidogenesis. 
4.2. Cyclic nucleotide l vels during stimulation of 
testosterone production by hCG 
It has been previously shown that maximal 
stimulation of testosterone production can be evoked 
by low concentrations of hCG which have no measur- 
able effect on cyclic AMP accumulation [6,8]. In 
addition, half-maximum testosterone production is 
stimulated by a concentration ofhCG approximately 
100-fold lower than that necessary to produce a 
half-maximum cyclic AMP production. The dose- 
response relationship between hCG concentration, 
cyclic AMP formation and testosterone production 
during a 3-h incubation period is shown in fig. 1. 
Cyclic GMP production was also measured, but 
unlike cyclic AMP, was not significantly affected by 
hCG. 
To determine whether transient changes in cyclic 
nucleotidc formation occurred in the interstitial cells, 
cyclic GMP and cyclic AMP, as well as testosterone 
production, were measured at various times during 
incubation in the absence and presence of hCG. Two 
concentrations of hCG were used; one which stimu- 
lated testosterone production but did not alter cyclic 
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Fig.1. Testosterone and cyclic nucleotide production by isolated interstitial cells during incubation for 3 h with increasing 
concentrations of hCG. Values for testosterone (o - -o ) ,  cyclic AMP (o - -o ) ,  and cyclic GMP (zx..A) are expressed per 10 7 cells; 
each point represents he mean -+ SE of triplicate incubations. 
AMP levels during a 3-h incubation (0.1 ng/vial), and 
the other which caused maximum steroidogenesis and 
increased cyclic AMP levels (10 ng/vial) (fig. 1). The 
results, given in fig.2, show the expected effects of 
hCG on testosterone and cyclic AMP levels. However, 
neither concentration of hCG significantly altered 
cyclic GMP levels at any time during the incubation 
period. 
5. Discussion 
The role of cyclic GMP as a second messenger in
peptide hormone action has not been extensively 
investigated. Although cyclic GMP has been shown 
to act as an intermediate in the action of neuro- 
transmitters and related regulators [17], there is 
relatively little evidence about the role of the nucleo- 
tide in hormone action. The actions of estrogen upon 
the rat uterus have been shown to include stimulation 
of tissue levels of cyclic GMP [ 16]. Also, insulin has 
been reported to raise the level of cyclic GMP in liver 
cells [18], and ACTH has been shown to suppress 
cyclic GMP levels in the rat adrenal [19]. However, 
there is conflicting data about the actions of trophic 
hormones upon cyclic GMP formation in steroido- 
genic target issues. A rise in cyclic GMP during 
hormone stimulation was described by Sharma et al. 
[9], who reported that ACTH stimulated both 
cyclic GMP synthesis and corticosterone production in 
adrenal cells at concentrations which did not cause a 
measurable increase in synthesis of cyclic AMP. Such 
observations are not consistent with the report of 
Whitley et al. [19], who demonstrated that ACTH 
reduces cyclic GMP levels in the adrenal. Stimulation 
of cyclic GMP levels in ovarian tissue has been 
reported to occur after administration of gonado- 
tropin subunits to superovulated female rats [20]. 
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Fig.2. Production of testosterone and cyclic nucleotides 
during incubation of interstitial cells for up to 3 h in the 
presence of 0.I ng hCG per vial (open bars) and 10 ng hCG 
per vial (hatched bars). The control values for testosterone 
and cyclic nucleotides ateach time interval were subtracted 
from the levels measured in the presence of hCG, which are 
expressed per 107 ceils (-+ SE). 
However, this observation is difficult to interpret due 
to the absence of any effect of the intact hormone 
upon cyclic GMP during the same experiments, and 
the absence of detectable biological activity in sub- 
units of LH and hCG [21]. Thus, there are discre- 
pancies in the available data concerning the possible 
role of cyclic GMP in peptide hormone action. If 
such a stimulation of cyclic GMP did occur, it could 
provide an alternate mechanism for the steroidogenic 
action of trophic hormone at the low concentrations 
which are accompanied by a dissociation between 
cyclic AMP and steroidogenesis in the adrenal and 
testis. 
The results of the present experiments have clearly 
shown that this mechanism does not operate in the 
interstitial cells of the testis. Not only are cyclic GMP 
[22] and its dibutyryl derivative ineffective in 
stimulating testosterone production, but no change 
in cyclic GMP levels could be detected in Leydig cells 
during hormonal stimulation of testosterone synthesis. 
The absence of a cyclic GMP response to gonadotropin 
in dispersed interstitial cells was confirmed by studies 
performed with a wide range ofhCG concentrations, 
and at several time intervals during incubation with 
gonadotropin. Although the cyclic GMP assay was of 
adequate sensitivity to measure basal concentrations of
the nucleotide in dispersed interstitial cells, no change 
in cyclic GMP content was observed under any of the 
conditions employed to stimulate testosterone produc- 
tion. The ability of the cyclic GMP assay to measure 
a significant change in tissue cyclic GMP levels was 
demonstrated by confirming the observations of 
Kuehl et al. [16], that estradiol treatment is followed 
by increased cyclic GMP levels in the rat uterus. 
The absence of a change in cyclic GMP levels 
during gonadotropin stimulation of interstitial cells, 
and the lack of an effect of exogenous cyclic GMP 
upon steroidogenesis, indicate that cyclic GMP does 
not act as a secondmessenger in the actions of LH 
and hCG upon the testis. 
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